The city’s pharma giants avoided much of the initial turbulence felt by the rest of the economy in the wake of President Donald Trump’s sweeping tariffs. The S&P 500 cratered Thursday ...

LONDON/BENGALURU April 3 (Reuters) - Drugmaker stocks gained a temporary reprieve ... the president plans separate tariffs targeting the pharma sector. Trump in his White House Rose Garden ...

READ ALSO: 10 Best Performing Pharma Stocks So Far in 2025 and 11 Best Pharma Stocks to Buy According to Hedge Funds. We further discussed the potential impacts of Trump’s tariffs and the ...

According to TipRanks, Ahmad has an average return of -2.8% and a 45.17% success rate on recommended stocks. Inozyme Pharma has an analyst consensus of Strong Buy, with a price target consensus of ...